Vatché Bartekian,
With more than 28 years of experience in the pharmaceutical and biotechnology sectors, Vatché brings deep expertise in global drug development and the operational execution of complex, high-risk clinical programs.
He brings extensive experience leading complex, multicenter clinical programs requiring high methodological precision, cross-functional coordination, and rigorous regulatory oversight. His leadership emphasizes scientific integrity, proactive risk identification and mitigation, and disciplined execution—critical elements for imaging-driven, diagnostic validation, medical device, and early- to late-phase development programs where endpoint protection and data reliability are paramount. Under his direction, Vantage BioTrials has established itself as a trusted partner for sponsors seeking structured governance, collaborative engagement, and compliant, high-quality clinical trial delivery in technically specialized and innovation-focused development environments.
Vahé Bartekian,
Vice President, Quality Management
Vahé brings more than three decades of experience in clinical research and clinical trial management, having been active in the CRO industry since 1993. He possesses deep expertise across GCP, GCLP, and GLP principles, with a career-long focus on operational excellence, regulatory compliance, and high-quality trial execution. As a co-founder and executive leader of Vantage BioTrials, Vahé has been instrumental in embedding Quality by Design (QbD) and risk-based methodologies into the organization’s clinical trial management framework, ensuring proactive risk mitigation and data integrity across complex, multinational studies. His leadership philosophy is grounded in clear communication, uncompromising quality standards, and full transparency—principles that consistently translate into strong sponsor partnerships, efficient trial delivery, and successful clinical outcomes.
Viken Bartekian,
Vice President, Corporate Development
With over 30 years of experience in the lifescience industry, Viken Bartekian is Vice President of Corporate Development and Co-Founder of Vantage BioTrials. Since co-founding the company in 2007, he has been instrumental in guiding its strategic growth and building long-term partnerships with biotech, pharmaceutical, and medical device sponsors. Viken oversees corporate and business development strategy, portfolio planning, and commercial operations, with a strong focus on aligning sponsor objectives with fit-for-purpose, risk-based clinical execution. His leadership has been central to establishing Vantage BioTrials as a trusted Canadian CRO known for disciplined trial management and consistent delivery of high-quality clinical outcomes.